Literature DB >> 2787099

Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.

C Merkel1, M Bolognesi, P Angeli, F Noventa, L Caregaro, D Sacerdoti, A Gatta.   

Abstract

Sixty-one patients with cirrhosis with varices without previous bleeding were admitted to our Department over a period of 2 yr. Fifty had alcoholic cirrhosis. Child-Turcotte-Pugh class was A in 11 patients, B in 30, and C in 20. Varices were F1 in 18, and F2-F3 in 43. During follow-up of up to 40 months, one patient was lost to follow-up and 22 patients died, seven of gastrointestinal bleeding and 15 of liver failure. The probability of death from any cause was significantly related to Child-Turcotte-Pugh class, ascites, encephalopathy, s-albumin, s-bilirubin, prothrombin index, and galactose elimination capacity. Independent prognostic variables according to Cox's model resulted s-albumin, s-bilirubin, encephalopathy, and varices. Considering only patients who died from liver failure, survival was univariately related to the same determinants, whereas the Cox's model individuated s-bilirubin, s-albumin, ascites, and galactose elimination capacity as independent prognostic indicators. Considering only patients who died from gastrointestinal bleeding no Cox model could be performed due to the small number of deaths. In patients with F1 varices, the probability of death from liver failure was 5 times higher than that from gastrointestinal bleeding; in patients with F2-F3 varices, liver failure and gastrointestinal bleeding each accounted for approximately half of the deaths. These data could become useful when programming a clinical trial of prophylaxis which considers reduction in mortality as the main end-point.

Entities:  

Mesh:

Year:  1989        PMID: 2787099

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  The liver, the brain and nitrogen metabolism.

Authors:  Piero Amodio
Journal:  Metab Brain Dis       Date:  2008-12-24       Impact factor: 3.584

2.  Hepatic encephalopathy therapy: An overview.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

3.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

4.  Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy.

Authors:  P Amodio; P Marchetti; F Del Piccolo; C Rizzo; R M Iemmolo; L Caregaro; G Gerunda; A Gatta
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

5.  Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.

Authors:  Chiranjeevi Gadiparthi; George Cholankeril; Eric R Yoo; Menghan Hu; Robert J Wong; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2018-04-02       Impact factor: 3.199

6.  Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices.

Authors:  M J Orloff; M S Orloff; M Rambotti; B Girard
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

7.  Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.

Authors:  Robert P Myers; Abdel Aziz M Shaheen; Peter Faris; Alexander I Aspinall; Kelly W Burak
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.